November 6, 2026
Once-Weekly TransCon® CNP (Navepegritide) to Receive 10 Years of Market Exclusivity Upon Approval in the European UnionNEWS RELEASES
Phase 1
Phase 2
Phase 3
TransCon hGH
Pediatric growth hormone deficiency2
test
Phase 2
test
Adult growth hormone deficiency
Phase 2
TransCon PTH
Adult hypoparathyroidism
Phase 3
Phase 1
Phase 2
Phase 3
sss
ss
Phase 2
ss
sdsd
sss
Phase 3
sss
sds
ss
ss